Singular Genomics to Present at the Goldman Sachs Global Healthcare Conference
June 01 2023 - 4:05PM
Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company
leveraging novel next-generation sequencing (NGS) and multiomics
technologies to empower researchers and clinicians, today announced
plans to present at the Goldman Sachs 44th Annual Global Healthcare
Conference in Dana Point, CA.
Singular Genomics’ management is scheduled to
participate in a fireside chat Tuesday, June 13, 2023, at 11:20
a.m. Pacific Time / 2:20 p.m. Eastern Time. Investors and other
interested parties are invited to listen to a live and recorded
webcast of the presentation at investor.singulargenomics.com, in
the News & Events section.
About Singular Genomics Systems,
Inc.
Singular Genomics is a life science technology
company that develops next-generation sequencing and multiomics
technologies. The commercially available G4 Sequencing Platform is
a powerful, highly versatile benchtop genomic sequencer designed to
produce fast and accurate results. In development, the PX system
leverages Singular’s proprietary sequencing technology, applying it
as an in situ readout to look at RNA and proteins in single cells
and tissue. With these products, Singular Genomics’ mission is to
empower researchers and clinicians to advance science and medicine.
Visit www.singulargenomics.com for more information.
Investor Contact
Matt
Clawson949-370-8500ir@singulargenomics.com
Media Contact
Dan Budwick, 1AB973-271-6085dan@1abmedia.com
Singular Genomics Systems (NASDAQ:OMIC)
Historical Stock Chart
From Apr 2024 to May 2024
Singular Genomics Systems (NASDAQ:OMIC)
Historical Stock Chart
From May 2023 to May 2024